|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013216,
umls-concept:C0242792,
umls-concept:C0281548,
umls-concept:C0332283,
umls-concept:C0332293,
umls-concept:C0543467,
umls-concept:C0600558,
umls-concept:C0683598,
umls-concept:C1140680,
umls-concept:C1516213,
umls-concept:C1519429,
umls-concept:C2603343,
umls-concept:C2698872
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2010-2-17
|
|
pubmed:abstractText |
In vitro testing of the activity of chemotherapeutic agents has been suggested as 1 method to optimally select drugs for patients with ovarian cancer. There are limited prospectively obtained data examining the clinical utility of this approach. We sought to obtain a preliminary assessment of this strategy in a trial that examined the administration of neoadjuvant chemotherapy followed by surgical cytoreduction and intraperitoneal chemotherapy in women with advanced ovarian cancer.
|
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/CA105409,
http://linkedlifedata.com/resource/pubmed/grant/CA12213,
http://linkedlifedata.com/resource/pubmed/grant/CA12644,
http://linkedlifedata.com/resource/pubmed/grant/CA13612,
http://linkedlifedata.com/resource/pubmed/grant/CA22433,
http://linkedlifedata.com/resource/pubmed/grant/CA32102,
http://linkedlifedata.com/resource/pubmed/grant/CA35176,
http://linkedlifedata.com/resource/pubmed/grant/CA35261,
http://linkedlifedata.com/resource/pubmed/grant/CA35262,
http://linkedlifedata.com/resource/pubmed/grant/CA35281,
http://linkedlifedata.com/resource/pubmed/grant/CA38926,
http://linkedlifedata.com/resource/pubmed/grant/CA45560,
http://linkedlifedata.com/resource/pubmed/grant/CA46368,
http://linkedlifedata.com/resource/pubmed/grant/CA46441,
http://linkedlifedata.com/resource/pubmed/grant/CA52654,
http://linkedlifedata.com/resource/pubmed/grant/CA58723,
http://linkedlifedata.com/resource/pubmed/grant/CA58861,
http://linkedlifedata.com/resource/pubmed/grant/CA67575,
http://linkedlifedata.com/resource/pubmed/grant/CA86780
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/20130422-11181662,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20130422-11745193,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20130422-12468336,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20130422-14634558,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20130422-16000215,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20130422-16394300,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20130422-1894174,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20130422-19138791,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20130422-8398914,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20130422-8960474,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20130422-9887245,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20130422-9889037
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1423-0232
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright (c) 2010 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
77
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
395-9
|
|
pubmed:dateRevised |
2011-7-22
|
|
pubmed:meshHeading |
pubmed-meshheading:20130422-Adult,
pubmed-meshheading:20130422-Aged,
pubmed-meshheading:20130422-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20130422-Combined Modality Therapy,
pubmed-meshheading:20130422-Disease-Free Survival,
pubmed-meshheading:20130422-Drug Resistance, Neoplasm,
pubmed-meshheading:20130422-Female,
pubmed-meshheading:20130422-Humans,
pubmed-meshheading:20130422-Injections, Intraperitoneal,
pubmed-meshheading:20130422-Middle Aged,
pubmed-meshheading:20130422-Neoplasm Staging,
pubmed-meshheading:20130422-Ovarian Neoplasms
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: a Southwest Oncology Group Study.
|
|
pubmed:affiliation |
New York University Cancer Center, New York, NY 10016, USA. amy.tiersten@nyumc.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
